Gedatolisib is the first approved agent to inhibit class I PI3K isoforms plus both mTOR complexes, addressing a long-standing challenge in comprehensive PI3K/AKT/mTOR pathway blockade. The indication ...

Analyses spanning 35,245 patients across 13 scenarios found comparable initiation of any systemic therapy in Medicare ...

Daily incident cases declined to 1 on July 12, while cumulative burden reached 60 cases with 15 hospitalizations and no fatalities by July 13. Thirty-one buildings were PCR-positive for Legionella, ...

In the second and final part of her interview with The American Journal of Managed Care ® (AJMC ®), Cherie Daly, MD, director ...

KFF tested four myths spanning MMR-autism, measles vaccine harms, COVID-19 vaccine mortality, and mRNA DNA alteration, finding sizable endorsement across the population. Having a trusted clinician ...

Minnesota’s $515 million quarterly withholding and subsequent $1.3 billion deferral signal a more punitive federal stance that could normalize aggressive liquidity controls over state Medicaid ...

Once-weekly 500 mg subcutaneous initiation is delivered by autoinjector as two 250 mg injections, allowing self- or caregiver administration at home rather than clinic-based IV starts. FDA acceptance ...

June author Erin L. Duffy, PhD, MPH, discusses her study showing nonprofit and system-affiliated hospitals provide greater access to translated financial assistance documents. During her conversation ...

INCA033989 showed encouraging spleen, anemia, and molecular responses in mutant calreticulin myelofibrosis, suggesting ...

In the final episode, 'Fixing the Mental Health System: Burnout, Advocacy, and the Case for Team-Based Care,' the panelists ...

Survivorship care and patient follow-up, being pivotal to managing treatment plans for patients with breast cancer, were key ...

Jennifer Sheng, MD, discusses how multidisciplinary collaboration, tumor boards, and coordinated care improve breast cancer ...